Neuroendocrine Tumors: Targeted Therapies

An overview of neuroendocrine tumors and comprehensive insight on the novel targeted therapies that are improving outcomes for patients.

EP. 1: Understanding the Diagnosis and Prognosis of Neuroendocrine Tumors

August 20th 2021

Diane Reidy-Lagunes, MD, provides an overview of neuroendocrine tumors, along with specific considerations for optimal diagnosis and prognostication.

EP. 2: Neuroendocrine Tumor Pathogenesis and Molecular Testing

August 20th 2021

Expert insight on the pathogenesis of neuroendocrine tumors and the best use of molecular testing to inform treatment decisions.

EP. 3: An Overview of Treatment Approaches for Neuroendocrine Tumors

August 27th 2021

Standard treatment pathways for patients with neuroendocrine tumors involving systemic therapy, surgery, and radiation.

EP. 4: Neuroendocrine Tumors: Factors That Inform Therapy Selection

August 27th 2021

A detailed explanation on how disease and patient factors inform selection from the treatment armamentarium for neuroendocrine tumors.

EP. 5: Systemic Therapy for Advanced Neuroendocrine Tumors

September 3rd 2021

Diane Reidy-Lagunes, MD, outlines goals of therapy and selection of systemic therapy for patients with neuroendocrine tumors.

EP. 6: Advanced Neuroendocrine Tumors: VEGF-Targeted Therapies

September 3rd 2021

Expert reflections on VEGF-targeted therapy’s role in the treatment of patients with neuroendocrine tumors.

EP. 7: Advanced Neuroendocrine Tumors: Clinical Trials With Surufatinib

September 10th 2021

Considerations for use of surufatinib in patients with neuroendocrine tumors in light of the SANET-p and SANET-ep clinical trials.

EP. 8: Future Directions in the Management of Neuroendocrine Tumors

September 10th 2021

Looking toward the future management of neuroendocrine tumors, Diane Reidy-Lagunes, MD, shares insight on possible therapy evolutions and ongoing unmet needs.

EP. 9: The Nature of Neuroendocrine Tumors

September 17th 2021

Expert insight on the subtypes of neuroendocrine tumors and current understanding of the disease microenvironment.

EP. 10: Neuroendocrine Tumors: Options for Initial Therapy

September 17th 2021

Matthew H. Kulke, MD, provides a broad overview of initial therapy options available for patients with neuroendocrine tumors.